Delta Investment Management LLC Has $3.39 Million Holdings in UnitedHealth Group Incorporated (NYSE:UNH)

Delta Investment Management LLC grew its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 167.3% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 6,696 shares of the healthcare conglomerate's stock after buying an additional 4,191 shares during the quarter. UnitedHealth Group makes up 0.7% of Delta Investment Management LLC's portfolio, making the stock its 27th largest position. Delta Investment Management LLC's holdings in UnitedHealth Group were worth $3,387,000 as of its most recent SEC filing.

Other hedge funds also recently modified their holdings of the company. Capital & Planning LLC increased its position in UnitedHealth Group by 19.2% during the fourth quarter. Capital & Planning LLC now owns 491 shares of the healthcare conglomerate's stock worth $248,000 after buying an additional 79 shares during the last quarter. My Legacy Advisors LLC raised its holdings in UnitedHealth Group by 1.6% in the 4th quarter. My Legacy Advisors LLC now owns 4,812 shares of the healthcare conglomerate's stock valued at $2,615,000 after acquiring an additional 78 shares during the period. Delta Capital Management LLC boosted its holdings in shares of UnitedHealth Group by 0.8% during the fourth quarter. Delta Capital Management LLC now owns 7,250 shares of the healthcare conglomerate's stock worth $3,667,000 after acquiring an additional 60 shares during the period. Brady Martz Wealth Solutions LLC bought a new position in shares of UnitedHealth Group during the fourth quarter worth approximately $978,000. Finally, Client 1ST Advisory Group LLC bought a new stake in UnitedHealth Group in the 4th quarter valued at $292,000. Institutional investors own 87.86% of the company's stock.

Insiders Place Their Bets

In other UnitedHealth Group news, CFO John F. Rex acquired 17,175 shares of the business's stock in a transaction that occurred on Friday, May 16th. The stock was bought at an average cost of $291.12 per share, with a total value of $4,999,986.00. Following the acquisition, the chief financial officer now owns 203,796 shares in the company, valued at approximately $59,329,091.52. This represents a 9.20% increase in their ownership of the stock. The purchase was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, CEO Stephen J. Hemsley purchased 86,700 shares of the business's stock in a transaction dated Friday, May 16th. The stock was bought at an average cost of $288.57 per share, with a total value of $25,019,019.00. Following the completion of the acquisition, the chief executive officer now directly owns 679,493 shares of the company's stock, valued at approximately $196,081,295.01. This trade represents a 14.63% increase in their ownership of the stock. The disclosure for this purchase can be found here. Insiders bought 109,408 shares of company stock valued at $31,607,768 over the last ninety days. 0.33% of the stock is currently owned by insiders.

UnitedHealth Group Price Performance

UnitedHealth Group stock opened at $315.80 on Tuesday. The company has a quick ratio of 0.91, a current ratio of 0.83 and a debt-to-equity ratio of 0.74. The stock has a market cap of $286.47 billion, a P/E ratio of 20.37, a P/E/G ratio of 1.37 and a beta of 0.56. The company's 50 day moving average price is $467.51 and its two-hundred day moving average price is $511.49. UnitedHealth Group Incorporated has a 52 week low of $248.88 and a 52 week high of $630.73.

UnitedHealth Group (NYSE:UNH - Get Free Report) last released its earnings results on Thursday, April 17th. The healthcare conglomerate reported $7.20 EPS for the quarter, missing analysts' consensus estimates of $7.29 by ($0.09). UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. The business had revenue of $109.58 billion for the quarter, compared to the consensus estimate of $111.56 billion. During the same quarter in the previous year, the firm earned $6.91 earnings per share. On average, equities analysts predict that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.

UnitedHealth Group Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, March 18th. Investors of record on Monday, March 10th were paid a $2.10 dividend. The ex-dividend date was Monday, March 10th. This represents a $8.40 annualized dividend and a yield of 2.66%. UnitedHealth Group's payout ratio is 35.18%.

Analyst Ratings Changes

A number of equities analysts have commented on the company. Truist Financial restated a "buy" rating and set a $360.00 price objective (down previously from $580.00) on shares of UnitedHealth Group in a research note on Monday. Hsbc Global Res downgraded UnitedHealth Group from a "strong-buy" rating to a "hold" rating in a research note on Tuesday, April 22nd. Oppenheimer dropped their target price on shares of UnitedHealth Group from $600.00 to $400.00 and set an "outperform" rating for the company in a research report on Wednesday, May 14th. Barclays decreased their price objective on shares of UnitedHealth Group from $513.00 to $362.00 and set an "overweight" rating on the stock in a research note on Thursday, May 15th. Finally, Deutsche Bank Aktiengesellschaft decreased their target price on UnitedHealth Group from $521.00 to $362.00 and set a "buy" rating on the stock in a research report on Wednesday, May 14th. Eight analysts have rated the stock with a hold rating, seventeen have given a buy rating and one has given a strong buy rating to the company's stock. Based on data from MarketBeat, the stock presently has a consensus rating of "Moderate Buy" and a consensus target price of $454.23.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.